NCT01475045CompletedNot Applicable
Multicenter, Prospective, Non Interventional Observational Study in Treatments of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Elpen Pharmaceutical Co. Inc.2 sites in 1 country1,160 target enrollmentStarted: January 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 1,160
- Locations
- 2
- Primary Endpoint
- Patients' satisfaction
Study Overview
Brief Summary
The aim of the study is to compare patients' satisfaction from the use of three different inhalation devices by using the FSI-10 questionnaire
Detailed Description
Patients are requested to reply to FSI-10 questionnaire regarding their satisfaction from inhalation devices. Patients are on 3 different asthma inhalation devices with combination treatment (Turbuhaler, Diskus, Elpenhaler)
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients > 18 years old, both genders who are on their inhalation treatment at least two months before study enrollment,
- •Who are able to be compliant to study procedures
Exclusion Criteria
- •Patients < 18 years old,
- •Patients who are on their inhalation treatment less than two months before study enrollment
- •Patients who are not able to be compliant to study procedures
Outcomes
Primary Outcomes
Patients' satisfaction
Time Frame: all study period (5 months)
Patients' replies to FSI-10 questionnaire valid in Greek language
Secondary Outcomes
- Patients devices' use(all study period (5 months))
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD TreatmentPatient SatisfactionNCT02384577Teva Pharma GmbH4,034
Completed
Phase 4
Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD PatientsChronic Obstructive Pulmonary Disease (COPD)NCT01727024Novartis Pharmaceuticals140
Completed
Not Applicable
Re-usable Respimat® Soft MistTM Inhaler StudyPulmonary Disease, Chronic ObstructiveNCT04011735Boehringer Ingelheim262
Completed
Not Applicable
Evaluating inhaler use technique and satisfaction with inhaler devices in Japanese patients with COPDJPRN-UMIN000033527Juntendo University155
Terminated
Phase 4
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugSchizophreniaNCT01592201Janssen Korea, Ltd., Korea13